| Literature DB >> 12431026 |
Ijeoma A Azodo1, Eli D Ehrenpreis.
Abstract
Alvimopan is a potent, peripherally active, mu-opioid receptor antagonist being developed by Adolor and GlaxoSmithKline (GSK) as a potential treatment for post-operative ileus and opioid bowel dysfunction.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12431026
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN： 1472-4472